Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morpho-anatomical and biochemical plasticity of chia (Salvia hispanica L.) microgreens following heavy-ion seed irradiation.

Plant physiology and biochemistry : PPB·2026
Same author

The future is not always uniform: rethinking radiotherapy through spatial fractionation.

Nature reviews. Clinical oncology·2026
Same author

Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomes.

Journal of applied clinical medical physics·2026
Same author

Micro CT calibration accuracy for pre-clinical studies in ion therapy.

Physics in medicine and biology·2026
Same author

Upright and supine particle therapy of lung cancer: A 4D dosimetric comparison.

Medical physics·2026
Same author

Correction: Base-excision repair increases DNA double-strand break clustering within heavy-ion tracks and modulates repair at δ-electron-induced breaks.

Scientific reports·2026
Same journal

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Nature reviews. Clinical oncology·2026
Same journal

Patient value over patent value: the mandate for open-source oncology.

Nature reviews. Clinical oncology·2026
Same journal

Cancer burden and control in China: landscape, trends and challenges.

Nature reviews. Clinical oncology·2026
Same journal

Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.

Nature reviews. Clinical oncology·2026
Same journal

New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.

Nature reviews. Clinical oncology·2026
Same journal

Teclistamab monotherapy improves survival in RRMM.

Nature reviews. Clinical oncology·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Charged particle therapy--optimization, challenges and future directions.

Jay S Loeffler1, Marco Durante

  • 1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

Nature Reviews. Clinical Oncology
|May 22, 2013
PubMed
Summary
This summary is machine-generated.

Charged particle therapy offers precise tumor control with less damage to healthy tissue compared to X-rays. While promising, more clinical trials are needed to confirm its cost-effectiveness for cancer treatment.

More Related Videos

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Experiment Videos

Last Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiobiology

Background:

  • Charged particle therapy, including protons and heavy ions, provides more selective energy deposition than X-rays.
  • This selectivity allows for higher tumor control and reduced damage to surrounding healthy tissues, leading to fewer complications and faster recovery.

Purpose of the Study:

  • To review the advantages of charged particle therapy over conventional radiotherapy.
  • To highlight its potential in treating radio-sensitive areas and challenging anatomical sites.
  • To discuss the current evidence and the need for more randomized clinical trials comparing particle therapy with X-rays.

Main Methods:

  • Review of current trial outcomes and medical physics/radiobiology research.
  • Comparison of energy deposition characteristics between charged particles and X-rays.
  • Analysis of potential benefits for tumor control and patient recovery.

Main Results:

  • Charged particle therapy demonstrates superior local tumor control and reduced risk of complications.
  • It is particularly beneficial for tumors near radiosensitive tissues and in difficult-to-access locations.
  • Current data suggests it may be a viable alternative to surgery in some cases.

Conclusions:

  • Charged particle therapy presents significant advantages for non-invasive tumor control.
  • Further controlled clinical trials are essential to establish a definitive cost:benefit ratio.
  • Ongoing research aims to reduce costs and enhance the benefits of this advanced cancer treatment.